Serina Therapeutics (SER)

NeuroAirmid Therapeutics, Inc. • ReCyte Therapeutics, Inc. • Reverse Bioengineering, Inc. • UniverXome Bioengineering, Inc. • Canaria Transaction Corporation ...

IRS number

821436829

SER stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

8-K

Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors

12 Feb 25

8-K

Regulation FD Disclosure

3 Feb 25

8-K

Departure of Directors or Certain Officers

14 Jan 25

8-K

Results of Operations and Financial Condition

6 Jan 25

8-K

Entry into a Material Definitive Agreement

23 Dec 24

8-K

Departure of Directors or Certain Officers

18 Dec 24

8-K

Regulation FD Disclosure

11 Dec 24

8-K

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate

2 Dec 24

424B3

Prospectus supplement

22 Nov 24

8-K

Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

12 Nov 24

Latest ownership filings

View all

Change in insider ownership

BROADWOOD PARTNERS, L.P.

Financial summary

Financial statements Chart SER financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	3.29 mm	3.29 mm	3.29 mm	3.29 mm	3.29 mm	3.29 mm
Cash burn (monthly)	959.67 k	460.08 k	1.77 mm	938.05 k	987.33 k	1.04 mm
Cash used (since last report)	4.38 mm	2.10 mm	8.09 mm	4.29 mm	4.51 mm	4.73 mm
Cash remaining	-1.10 mm	1.18 mm	-4.81 mm	-1.00 mm	-1.23 mm	-1.45 mm
Runway (months of cash)	-1.1	2.6	-2.7	-1.1	-1.2	-1.4

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q1 2024

SER institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	2	5	-60.0%
Opened positions	0	0
Closed positions	3	27	-88.9%
Increased positions	0	2	EXIT
Reduced positions	1	0	NEW

13F shares	Current	Prev Q	Change
Total value	37.70 mm	73.20 mm	-48.5%
Total shares	88.81 mm	90.29 mm	-1.6%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Juvenescence	86.93 mm	$33.03 mm	-1.6%
Ibs Capital	1.88 mm	$4.67 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Juvenescence	86.93 mm	-1.39 mm	-1.6%
Strategic Wealth Designers	0.00	-97.38 k	EXIT
Piscataqua Savings Bank	0.00	-1.00 k	EXIT
Pacifica Partners	0.00	-292.00	EXIT
Ibs Capital	1.88 mm	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SER insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
12 Feb 25	Venkatesan Jay	Stock Option Common Stock	Grant	Acquire A	No	No	4.6	40,000	184.00 k	40,000
14 Jan 25	Karen J Wilson	Stock Option Common Stock	Grant	Acquire A	No	No	4.9	40,000	196.00 k	40,000
17 Dec 24	Bailey Gregory	Common Stock	Buy	Acquire P	No	No	4.5899	3,866	17.74 k	67,243